Targeted molecular therapies are reshaping the landscape of cancer treatments by offering precise interventions that disrupt the fundamental processes driving tumor growth.Recent developments in cancer research have unveiled innovative methods to understand and manipulate the intricate protein interactions involved in oncogenic processes, such as those seen in aggressive cancers like medulloblastoma.